The Oncology Institute, Inc. (NASDAQ:STLN) — Market Cap & Net Worth
Market Cap & Net Worth: The Oncology Institute, Inc. (STLN)
The Oncology Institute, Inc. (NASDAQ:STLN) has a market capitalization of $640.89 Million ($640.89 Million) as of August 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11113 globally and #2899 in its home market, demonstrating a 29.26% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying The Oncology Institute, Inc.'s stock price $6.45 by its total outstanding shares 99982933 (99.98 Million). See The Oncology Institute, Inc. net asset quality index to understand what proportion of total assets are financed by equity.
The Oncology Institute, Inc. Market Cap History: 2026 to 2026
The Oncology Institute, Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $644.89 Million to $644.89 Million (0.00% CAGR). Also see The Oncology Institute, Inc. asset portfolio for a full breakdown of the balance sheet.
The Oncology Institute, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how The Oncology Institute, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest The Oncology Institute, Inc. stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of STLN by Market Capitalization
Companies near The Oncology Institute, Inc. in the global market cap rankings as of August 17, 2026. Also see STLN cash flow conversion for how efficiently the company converts equity into cash flow.
Key companies related to The Oncology Institute, Inc. by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #304 globally with a market cap of $89.77 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #931 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1012 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1262 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #304 | HCA Healthcare, Inc. | NYSE:HCA | $89.77 Billion | $404.68 |
| #931 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.08 |
| #1012 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1262 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $267.90 |
The Oncology Institute, Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, The Oncology Institute, Inc.'s market cap moved from $644.89 Million to $ 644.89 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $644.89 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 17th, 2026 the market cap of The Oncology Institute, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $640.89 Million USD |
| MoneyControl | $640.89 Million USD |
| MarketWatch | $640.89 Million USD |
| marketcap.company | $640.89 Million USD |
| Reuters | $640.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About The Oncology Institute, Inc.
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educatio… Read more